Form D · Biotechnology

CAMBRIDGE HEART INC

Tewksbury, MA · CIK 0000913443

Offering snapshot reported Mar 9, 2012 · SEC filing

Reported sold
$2.94M
Offering amount: $4M
Investors reported
20
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Jan 17, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.47M$2.94MJan 26, 2012: $2,500,000.00Jan 26, 2012Mar 9, 2012: $2,940,000.00Mar 9, 2012

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,500,000 → $2,940,000
  • Reported investors16 → 20
  • Minimum accepted$50,000 → $25,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 9, 2012Amendment$2,940,000$440,000vs Jan 26, 201220SEC filing
Jan 26, 2012Initial$2,500,000No comparison16SEC filing
Dec 22, 2010Initial$2,900,000No comparison49SEC filing
Dec 29, 2009Initial$1,852,000No comparison11SEC filing
Apr 5, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$281K
Finders' fees
$0
Form D file number
021-172469
In addition, Dawson James Securities, Inc. will also receive a 10% cash commission on the gross proceeds received by the company from the exercise of the warrants.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Dawson James Securities, Inc.130645

Source: Form D, filed Mar 9, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard J. Cohen, M.D., Ph.D. Director
Roderick De Greef Director, Executive
Kenneth V. Hachikian Director
Ali Haghighi Mood, Ph.D. Director, Executive
Vincenzo Licausi Executive
Vincenzo Li Causi Executive
Reed Malleck Director
Paul Mc Cormick Director
John F. Mc Guire Director
Jeffrey Wiggins Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
100 Ames Pond Road
Tewksbury, MA, 01876